A comparative study of the effects of ABT-418 and methylphenidate on spatial memory in an animal model of ADHD

Neuroscience Letters

Volumn 528, Issue 1, 2012, Pages 11-15

  Guo, Tianyou ^a,b   Yang, Chuang ^a,c   Guo, Lanting ^a   Liu, Kezhi ^a  

^a SICHUAN UNIVERSITY   (China)

^b SHENZHEN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

ABT 418; Attention deficit hyperactivity disorder (ADHD); Methylphenidate (MPH); Nicotinic acetylcholine receptor (nAChR); Spatial memory; Spontaneously hypertensive rats (SHRs)

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; METHYLPHENIDATE; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ESCAPE BEHAVIOR; HIPPOCAMPUS; LATENT PERIOD; LEARNING DISORDER; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; REFERENCE MEMORY; SPATIAL MEMORY; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; ISOXAZOLES; MALE; MAZE LEARNING; MEMORY; METHYLPHENIDATE; NICOTINIC AGONISTS; PYRROLIDINES; RATS; RATS, INBRED SHR; RECEPTORS, NICOTINIC;

EID: 84866905338     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.08.068     Document Type: Article

References (32)

1. Aguiar A., Eubig P.A., Schantz S.L. Attention deficit/hyperactivity disorder: a focused overview for children's environmental health researchers. Environmental Health Perspectives 2010, 118:1646-1653.
2. Apostol G., Abi-Saab W., Kratochvil C.J., Adler L.A., Robieson W.Z., Gault L.M., Pritchett Y.L., Feifel D., Collins M.A., Saltarelli M.D. Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology (Berlin) 2012, 219:715-725.
3. Arime Y., Kubo Y., Sora I. Animal models of attention-deficit/hyperactivity disorder. Biological & Pharmaceutical Bulletin 2011, 34:1373-1376.
4. Bekker E.M., Bocker K.B., Van Hunsel F., van den Berg M.C., Kenemans J.L. Acute effects of nicotine on attention and response inhibition. Pharmacology Biochemistry and Behavior 2005, 82:539-548.
5. Biederman J. Attention-deficit/hyperactivity disorder: a life-span perspective. Journal of Clinical Psychiatry 1998, 59(Suppl. 7):4-16.
6. Briggs C.A., McKenna D.G., Piattoni-Kaplan M. Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands. Neuropharmacology 1995, 34:583-590.
7. Davis J.A., Kenney J.W., Gould T.J. Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. Journal of Neuroscience 2007, 27:10870-10877.
8. Decker M.W., Curzon P., Brioni J.D., Arneric S.P. Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. European Journal of Pharmacology 1994, 261:217-222.
9. Gattu M., Pauly J.R., Boss K.L., Summers J.B., Buccafusco J.J. Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors, I. Brain Research 1997, 771:89-103.
10. Kraemer M., Uekermann J., Wiltfang J., Kis B. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature. Clinical Neuropharmacology 2010, 33:204-206.
11. Levin E.D., Christopher N.C., Briggs S.J., Rose J.E. Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Brain Research. Cognitive Brain Research 1993, 1:137-143.
12. Levin E.D., Conners C.K., Sparrow E., Hinton S.C., Erhardt D., Meck W.H., Rose J.E., March J. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 1996, 123:55-63.
13. Martinussen R., Hayden J., Hogg-Johnson S., Tannock R. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2005, 44:377-384.
14. Mosholder A.D., Gelperin K., Hammad T.A., Phelan K., Johann-Liang R. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children. Pediatrics 2009, 123:611-616.
15. O'Keefe J. Hippocampus, theta, and spatial memory. Current Opinion in Neurobiology 1993, 3:917-924.
16. Papke R.L., Thinschmidt J.S., Moulton B.A., Meyer E.M., Poirier A. Activation and inhibition of rat neuronal nicotinic receptors by ABT-418. British Journal of Pharmacology 1997, 120:429-438.
17. Potter A., Corwin J., Lang J., Piasecki M., Lenox R., Newhouse P.A. Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease. Psychopharmacology 1999, 142:334-342.
18. Prediger R.D., Pamplona F.A., Fernandes D., Takahashi R.N. Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD) - the spontaneously hypertensive rat (SHR). International Journal of Neuropsychopharmacology 2005, 8:583-594.
19. Rader R., McCauley L., Callen E.C. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder. American Family Physician 2009, 79:657-665.
20. Rodriguez A., Jarvelin M.R., Obel C., Taanila A., Miettunen J., Moilanen I., Henriksen T.B., Pietilainen K., Ebeling H., Kotimaa A.J., Linnet K.M., Olsen J. Do inattention and hyperactivity symptoms equal scholastic impairment? Evidence from three European cohorts. BMC Public Health 2007, 7:327.
21. Russell V., de Villiers A., Sagvolden T., Lamm M., Taljaard J. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Brain Research 1995, 676:343-351.
22. Russell V.A., Sagvolden T., Johansen E.B. Animal models of attention-deficit hyperactivity disorder. Behavioral and Brain Functions 2005, 1:9.
23. Russell V.A., Wiggins T.M. Increased glutamate-stimulated norepinephrine release from prefrontal cortex slices of spontaneously hypertensive rats. Metabolic Brain Disease 2000, 15:297-304.
24. Sagvolden T., Johansen E.B., Aase H., Russell V.A. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behavioral and Brain Functions 2005, 28:397-419. discussion 419-468.
25. Spencer T., Biederman J. Non-stimulant treatment for attention-deficit/hyperactivity disorder. Journal of Attention Disorders 2002, 6(Suppl. 1):S109-S119.
26. van den Bergh F.S., Bloemarts E., Chan J.S., Groenink L., Olivier B., Oosting R.S. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder. Pharmacology Biochemistry and Behavior 2006, 83:380-390.
27. Wigal S.B. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs 2009, 23(Suppl. 1):21-31.
28. Wilens T.E., Biederman J., Spencer T.J., Bostic J., Prince J., Monuteaux M.C., Soriano J., Fine C., Abrams A., Rater M., Polisner D. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. American Journal of Psychiatry 1999, 156:1931-1937.
29. Wilens T.E., Decker M.W. Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochemical Pharmacology 2007, 74:1212-1223.
30. Wilens T.E., Faraone S.V., Biederman J. Attention-deficit/hyperactivity disorder in adults. Journal of the American Medical Association 2004, 292:619-623.
31. Wilens T.E., Verlinden M.H., Adler L.A., Wozniak P.J., West S.A. A.B.T-089 a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study. Biological Psychiatry 2006, 59:1065-1070.
32. Zolles G., Wagner E., Lampert A., Sutor B. Functional expression of nicotinic acetylcholine receptors in rat neocortical layer 5 pyramidal cells. Cerebral Cortex 2009, 19:1079-1091.